| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/09/2023 | ALIMERA SCIENCES INC | ALIM | Grant | Employee Stock Option (Right to Buy) | 52.5k | $2.82 | $148k | | 01/09/2023 |
| 01/09/2023 | ALIMERA SCIENCES INC | ALIM | Grant | Common Stock | 17.5k | $0.00 | $0 | | 01/09/2023 |
| 09/09/2022 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 80k | $1.66 | $132.8k | | 09/09/2022 |
| 09/15/2020 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 150k | $1.22 | $183k | | 09/15/2020 |
| 09/15/2020 | ROCKWELL MEDICAL, INC. | RMTI | Grant | Stock Option (Right to Buy) | 600k | $1.22 | $732k | | 09/15/2020 |
| 12/18/2018 | Lineage Cell Therapeutics, Inc. | BTX | Payment of Exercise | Common Shares, no par value | 7.8k | $1.03 | $8k | | 12/18/2018 |
| 12/18/2018 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Restricted Stock Units | 22.5k | $0.00 | $0 | | 12/18/2018 |
| 10/04/2018 | Lineage Cell Therapeutics, Inc. | BTX | Exercise | Restricted Stock Units | 11.2k | $0.00 | $0 | | 10/04/2018 |
| 10/04/2018 | Lineage Cell Therapeutics, Inc. | BTX | Payment of Exercise | Common Shares, no par value | 3.9k | $2.22 | $8.6k | | 10/04/2018 |
| 03/15/2018 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 150k | $2.54 | $381k | | 03/15/2018 |
| 06/06/2017 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 250k | $3.16 | $790k | | 06/06/2017 |
| 09/08/2016 | Lineage Cell Therapeutics, Inc. | BTX | Grant | Option to Purchase Common Shares | 50k | $3.49 | $174.5k | | 09/08/2016 |
| 03/08/2013 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Grant | Non-qualified Stock Option (right to buy) | 150k | $0.38 | $57k | | 03/08/2013 |
| 05/23/2012 | AEOLUS PHARMACEUTICALS, INC. | AOLS | Purchase | Common Stock | 7k | $0.24 | $1.7k | | 05/23/2012 |